These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1647392)

  • 61. Bromocriptine-induced mania?
    Vlissides DN; Gill D; Castelow J
    Br Med J; 1978 Feb; 1(6111):510. PubMed ID: 626865
    [No Abstract]   [Full Text] [Related]  

  • 62. Ethosuximide intoxication caused by interaction with isoniazid.
    van Wieringen A; Vrijlandt CM
    Neurology; 1983 Sep; 33(9):1227-8. PubMed ID: 6684262
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Chronic mania-A sequel of cannabis use disorder!
    Kar SK; Dwivedi S; Shrivastava A; Tripathi A
    Aust N Z J Psychiatry; 2017 Aug; 51(8):847-848. PubMed ID: 27920061
    [No Abstract]   [Full Text] [Related]  

  • 64. Ephedrine-induced mania from an herbal diet supplement.
    Capwell RR
    Am J Psychiatry; 1995 Apr; 152(4):647. PubMed ID: 7694923
    [No Abstract]   [Full Text] [Related]  

  • 65. A case of ginseng-induced mania.
    Engelberg D; McCutcheon A; Wiseman S
    J Clin Psychopharmacol; 2001 Oct; 21(5):535-7. PubMed ID: 11593083
    [No Abstract]   [Full Text] [Related]  

  • 66. Fluoxetine induced mania in an adolescent : possible implications.
    Damodaran SS; Khanna R
    Indian J Psychiatry; 1992 Oct; 34(4):395-6. PubMed ID: 21776155
    [No Abstract]   [Full Text] [Related]  

  • 67. JWH-018 ω-OH, a shared hydroxy metabolite of the two synthetic cannabinoids JWH-018 and AM-2201, undergoes oxidation by alcohol dehydrogenase and aldehyde dehydrogenase enzymes in vitro forming the carboxylic acid metabolite.
    Holm NB; Noble C; Linnet K
    Toxicol Lett; 2016 Sep; 259():35-43. PubMed ID: 27421777
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cannabinoids and Cytochrome P450 Interactions.
    Zendulka O; Dovrtělová G; Nosková K; Turjap M; Šulcová A; Hanuš L; Juřica J
    Curr Drug Metab; 2016; 17(3):206-26. PubMed ID: 26651971
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cannabidiol enhances xenobiotic permeability through the human placental barrier by direct inhibition of breast cancer resistance protein: an ex vivo study.
    Feinshtein V; Erez O; Ben-Zvi Z; Eshkoli T; Sheizaf B; Sheiner E; Holcberg G
    Am J Obstet Gynecol; 2013 Dec; 209(6):573.e1-573.e15. PubMed ID: 23933222
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Structural requirements for potent direct inhibition of human cytochrome P450 1A1 by cannabidiol: role of pentylresorcinol moiety.
    Yamaori S; Okushima Y; Masuda K; Kushihara M; Katsu T; Narimatsu S; Yamamoto I; Watanabe K
    Biol Pharm Bull; 2013; 36(7):1197-203. PubMed ID: 23811569
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cannabidiol is a potent inhibitor of the catalytic activity of cytochrome P450 2C19.
    Jiang R; Yamaori S; Okamoto Y; Yamamoto I; Watanabe K
    Drug Metab Pharmacokinet; 2013; 28(4):332-8. PubMed ID: 23318708
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Involvement of UDP-glucuronosyltransferases UGT1A9 and UGT2B7 in ethanol glucuronidation, and interactions with common drugs of abuse.
    Al Saabi A; Allorge D; Sauvage FL; Tournel G; Gaulier JM; Marquet P; Picard N
    Drug Metab Dispos; 2013 Mar; 41(3):568-74. PubMed ID: 23230132
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CB2 and TRPV1 receptors mediate cannabinoid actions on MDR1 expression in multidrug resistant cells.
    Arnold JC; Hone P; Holland ML; Allen JD
    Pharmacol Rep; 2012; 64(3):751-7. PubMed ID: 22814029
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison in the in vitro inhibitory effects of major phytocannabinoids and polycyclic aromatic hydrocarbons contained in marijuana smoke on cytochrome P450 2C9 activity.
    Yamaori S; Koeda K; Kushihara M; Hada Y; Yamamoto I; Watanabe K
    Drug Metab Pharmacokinet; 2012; 27(3):294-300. PubMed ID: 22166891
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Safety and side effects of cannabidiol, a Cannabis sativa constituent.
    Bergamaschi MM; Queiroz RH; Zuardi AW; Crippa JA
    Curr Drug Saf; 2011 Sep; 6(4):237-49. PubMed ID: 22129319
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluation of the effects of Mitragyna speciosa alkaloid extract on cytochrome P450 enzymes using a high throughput assay.
    Kong WM; Chik Z; Ramachandra M; Subramaniam U; Aziddin RE; Mohamed Z
    Molecules; 2011 Aug; 16(9):7344-56. PubMed ID: 21876481
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6.
    Yamaori S; Okamoto Y; Yamamoto I; Watanabe K
    Drug Metab Dispos; 2011 Nov; 39(11):2049-56. PubMed ID: 21821735
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Conjugation of synthetic cannabinoids JWH-018 and JWH-073, metabolites by human UDP-glucuronosyltransferases.
    Chimalakonda KC; Bratton SM; Le VH; Yiew KH; Dineva A; Moran CL; James LP; Moran JH; Radominska-Pandya A
    Drug Metab Dispos; 2011 Oct; 39(10):1967-76. PubMed ID: 21746969
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes.
    Jiang R; Yamaori S; Takeda S; Yamamoto I; Watanabe K
    Life Sci; 2011 Aug; 89(5-6):165-70. PubMed ID: 21704641
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: role of phenolic hydroxyl groups in the resorcinol moiety.
    Yamaori S; Ebisawa J; Okushima Y; Yamamoto I; Watanabe K
    Life Sci; 2011 Apr; 88(15-16):730-6. PubMed ID: 21356216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.